ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,795Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 617

$601K Total Retail Price of All Prescriptions

Rank: 53 out of 617

362 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 362 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 362 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 12,557 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 707 656 1 2
LEVOTHYROXINE SODIUM 569 551 2 1
AMLODIPINE BESYLATE 480 468 3 6
BENAZEPRIL HCL 404 388 4 44
OMEPRAZOLE 397 329 5 3
FUROSEMIDE 349 328 6 4
METOPROLOL TARTRATE 342 324 7 11
POTASSIUM CHLORIDE 339 339 8 10
LISINOPRIL 306 290 9 5
METFORMIN HCL 288 266 10 9
HYDROCODONE-ACETAMINOPHEN 241 222 S3 11 8
METOPROLOL SUCCINATE 230 206 12 12
ATORVASTATIN CALCIUM 221 186 13 14
WARFARIN SODIUM 212 178 14 7
TAMSULOSIN HCL 198 188 15 26
HYDROCHLOROTHIAZIDE 189 185 16 13
ATENOLOL 174 168 17 17
GABAPENTIN 170 150 18 16
SERTRALINE HCL 164 145 19 20
POLYETHYLENE GLYCOL 3350 162 157 20 32
ALLOPURINOL 158 140 21 27
CITALOPRAM HBR 154 108 22 18
DONEPEZIL HCL 141 141 23 30
ENALAPRIL MALEATE 130 121 24 34
ISOSORBIDE MONONITRATE ER 128 128 25 52
ALENDRONATE SODIUM 125 110 26 25
FAMOTIDINE 124 107 27 54
FENOFIBRATE 120 113 28 58
TRAMADOL HCL 117 98 29 15
FENTANYL 110 110 S2 30 45
MELOXICAM 109 107 31 24
GLIPIZIDE 106 96 32 82
CLOPIDOGREL 103 103 33 53
FLUTICASONE PROPIONATE 100 96 34 36
NEXIUM 92 90 35 43
ZOLPIDEM TARTRATE 91 90 36 23
RANITIDINE HCL 89 88 37 40
TRIAMTERENE-HCTZ 87 66 38 47
PREDNISONE 84 81 39 31
METOCLOPRAMIDE HCL 84 77 39 125
LOSARTAN POTASSIUM 83 78 41 22
LOVASTATIN 81 76 42 57
CLONIDINE HCL 81 78 42 55
GLIMEPIRIDE 79 79 44 33
DIOVAN 78 78 45 41
TERAZOSIN HCL 75 75 46 96
CARVEDILOL 72 51 47 19
AVODART 71 71 48 144
PRAVASTATIN SODIUM 71 71 48 21
NAMENDA 71 71 48 35
PLAVIX 70 70 51 86
SPIRIVA 68 60 52 61
DOXAZOSIN MESYLATE 67 67 53 79
ACTOS 65 57 54 85
DIGOXIN 63 51 55 48
OXYBUTYNIN CHLORIDE 60 60 56 88
DIVALPROEX SODIUM 59 45 57 111
LIPITOR 59 51 57 118
IPRATROPIUM-ALBUTEROL 57 57 59 151
DILTIAZEM ER 57 52 59 81
CRESTOR 54 54 61 28
TRICOR 53 42 62 83
FINASTERIDE 53 53 62 104
GLYBURIDE 52 52 R 64 84
FOSINOPRIL SODIUM 51 51 65 185
HYDRALAZINE HCL 50 47 66 164
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.